Mark D. Chen serves as Executive at SKYSTAR BIO-PHARMACEUTICAL CO, where they oversee executive responsibilities. Since joining the company, Mark D. Chen has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 4, 2012 involved receiving (via award) 21,112 shares valued at $54.5K.
Mark D. Chen currently holds 26,668 shares of SKYSTAR BIO-PHARMACEUTICAL CO (SKBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark D. Chen has been a net neutral trader of SKBO stock. They have purchased $0 and sold $0 worth of shares.
Mark D. Chen's most recent insider trade was on May 4, 2012, when they sold 21,112 shares at $2.58 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |